135 related articles for article (PubMed ID: 28636264)
1. Desmopressin in haemophilia: The need for a standardised clinical response and individualised test regimen.
Stoof SCM; Schütte LM; Leebeek FWG; Cnossen MH; Kruip MJHA
Haemophilia; 2017 Nov; 23(6):861-867. PubMed ID: 28636264
[TBL] [Abstract][Full Text] [Related]
2. Desmopressin in non-severe haemophilia A: Test-response and clinical outcomes in a single Canadian centre review.
Hews-Girard J; Rydz N; Lee A; Goodyear MD; Poon MC
Haemophilia; 2018 Sep; 24(5):720-725. PubMed ID: 30004154
[TBL] [Abstract][Full Text] [Related]
3. The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: Superiority or non-inferiority?
Schütte LM; Hodes LS; van Moort I; Stoof SCM; Leebeek FWG; Cnossen MH; de Maat MPM; Kruip MJHA
Haemophilia; 2020 Sep; 26(5):916-922. PubMed ID: 32713129
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
Schütte LM; Cnossen MH; van Hest RM; Driessens MHE; Fijnvandraat K; Polinder S; Beckers EAM; Coppens M; Eikenboom J; Laros-van Gorkom BAP; Meijer K; Nieuwenhuizen L; Mauser-Bunschoten EP; Leebeek FWG; Mathôt RAA; Kruip MJHA
BMJ Open; 2019 Apr; 9(4):e022719. PubMed ID: 31015264
[TBL] [Abstract][Full Text] [Related]
5. Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A.
Stoof SC; Sanders YV; Petrij F; Cnossen MH; de Maat MP; Leebeek FW; Kruip MJ
Thromb Haemost; 2013 Mar; 109(3):440-9. PubMed ID: 23348756
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Modelling to Predict FVIII:C Response to Desmopressin and Its Reproducibility in Nonsevere Haemophilia A Patients.
Schütte LM; van Hest RM; Stoof SCM; Leebeek FWG; Cnossen MH; Kruip MJHA; Mathôt RAA
Thromb Haemost; 2018 Apr; 118(4):621-629. PubMed ID: 29458233
[TBL] [Abstract][Full Text] [Related]
7. Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patients.
Romano LGR; Schütte LM; van Hest RM; Meijer K; Laros-van Gorkom BAP; Nieuwenhuizen L; Eikenboom J; Heubel-Moenen FCJI; Uitslager N; Coppens M; Fijnvandraat K; Driessens MHE; Polinder S; Cnossen MH; Leebeek FWG; Mathôt RAA; Kruip MJHA;
Haemophilia; 2024 Mar; 30(2):355-366. PubMed ID: 38343113
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin for the treatment of haemophilia.
Castaman G
Haemophilia; 2008 Jan; 14 Suppl 1():15-20. PubMed ID: 18173690
[TBL] [Abstract][Full Text] [Related]
9. DDAVP challenge tests in boys with mild/moderate haemophilia A.
Revel-Vilk S; Blanchette VS; Sparling C; Stain AM; Carcao MD
Br J Haematol; 2002 Jun; 117(4):947-51. PubMed ID: 12060135
[TBL] [Abstract][Full Text] [Related]
10. Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.
Mansouritorghabeh H; Shirdel A
J Thromb Haemost; 2016 Feb; 14(2):336-9. PubMed ID: 26599105
[TBL] [Abstract][Full Text] [Related]
11. Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A.
Nance D; Fletcher SN; Bolgiano DC; Thompson AR; Josephson NC; Konkle BA
Haemophilia; 2013 Sep; 19(5):720-6. PubMed ID: 23711294
[TBL] [Abstract][Full Text] [Related]
12. Desmopressin testing in haemophilia A patients and carriers: results of a multi centre survey.
Knöfler R; Koscielny J; Tauer JT; Huhn B; Gneuss A; Kuhlisch E; Hofmann A; Petros S; Aumann V; Franke D; Kentouche K; Syrbe G; Seeger K; Haberland H; Klamroth R
Hamostaseologie; 2012; 32(4):271-5. PubMed ID: 22940861
[TBL] [Abstract][Full Text] [Related]
13. Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A.
Castaman G; Mancuso ME; Giacomelli SH; Tosetto A; Santagostino E; Mannucci PM; Rodeghiero F
J Thromb Haemost; 2009 Nov; 7(11):1824-31. PubMed ID: 19719828
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin in moderate hemophilia A patients: a treatment worth considering.
Loomans JI; Kruip MJHA; Carcao M; Jackson S; van Velzen AS; Peters M; Santagostino E; Platokouki H; Beckers E; Voorberg J; van der Bom JG; Fijnvandraat K;
Haematologica; 2018 Mar; 103(3):550-557. PubMed ID: 29305412
[TBL] [Abstract][Full Text] [Related]
15. Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia A.
Shu M; Malcolmson C; Bouskill V; Stain AM; Wakefield C; Blanchette VS; Carcao MD
Haemophilia; 2024 Jan; 30(1):116-122. PubMed ID: 38037243
[TBL] [Abstract][Full Text] [Related]
16. Intranasal DDAVP induced increases in plasma von Willebrand factor alter the pharmacokinetics of high-purity factor VIII concentrates in severe haemophilia A patients.
Deitcher SR; Tuller J; Johnson JA
Haemophilia; 1999 Mar; 5(2):88-95. PubMed ID: 10215955
[TBL] [Abstract][Full Text] [Related]
17. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.
Arshad F; Stoof SC; Leebeek FW; Ruitenbeek K; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Kruip MJ; Lisman T
Liver Int; 2015 Jul; 35(7):1809-15. PubMed ID: 25522671
[TBL] [Abstract][Full Text] [Related]
18. [Desmopressin in hemophilia A and Von Willebrand's disease].
Castro Cabezas M; de Graaf JC; Kraayenhagen RJ; Freen M; Poortman J; Hart HC
Ned Tijdschr Geneeskd; 1991 Mar; 135(9):367-71. PubMed ID: 1901629
[TBL] [Abstract][Full Text] [Related]
19. Current dosing practices for perioperative factor VIII concentrate treatment in mild haemophilia A patients result in FVIII levels above target.
Schütte LM; de Rooij N; Hazendonk HCAM; Mathôt RAA; van Hest RM; Leebeek FWG; Cnossen MH; Kruip MJHA
Haemophilia; 2019 Nov; 25(6):960-968. PubMed ID: 31487098
[TBL] [Abstract][Full Text] [Related]
20. Moderate-intensity aerobic exercise vs desmopressin in adolescent males with mild hemophilia A: a randomized trial.
Kumar R; Dunn AL; Schneiderman JE; Gonzales A; Bouskill V; Widener P; Stanek J; Pluthero FG; Waller A; Tarango C; Ahuja S; Kerlin BA; Kahr WHA; Rand ML; Lillicrap D; Carcao M
Blood; 2022 Sep; 140(10):1156-1166. PubMed ID: 35839450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
